Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting.

Kyung Ho Lee,Tae Sun Han,Changsu Han,Won-Myong Bahk,Soo-Jung Lee,Ashwin A Patkar,Prakash S Masand,Chi-Un Pae

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology（2023）

引用 0|浏览2

暂无评分

摘要

This study has shown additional benefit of AGO treatment as combination or switching agent for MDD patients without full remission in routine practice. However, adequately-powered and well-controlled studies are necessary for generalization of the present findings.

查看译文

关键词

agomelatine treatment,major depressive disorder,naturalistic treatment setting,additional clinical benefit

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要